Paloma Partners’s Thermo Fisher Scientific TMO Stock Holding History

Paloma Partners’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-1,300	Closed	-$804K	–	1017
2024 Q3	$804K	Sell	1,300 -2,484	-66%	-$1.47M	0.02%	481
2024 Q2	$2.09M	Buy	+3,784	New	+$2.17M	0.06%	337
2023 Q4	–	Sell	-1,539	Closed	-$745K	–	934
2023 Q3	$779K	Buy	+1,539	New	+$820K	0.03%	411
2023 Q2	–	Sell	-533	Closed	-$288K	–	938
2023 Q1	$307K	Buy	+533	New	+$300K	0.01%	569
2022 Q2	–	Sell	-17	Closed	-$10K	–	1747
2022 Q1	$10K	Sell	17 -1,482	-99%	-$851K	﹤0.01%	1700
2021 Q4	$1M	Buy	+1,499	New	+$936K	0.01%	724
2021 Q3	–	Sell	-9,559	Closed	-$4.82M	–	1861
2021 Q2	$4.82M	Sell	9,559 -30,707	-76%	-$14.5M	0.09%	206
2021 Q1	$18.4M	Buy	40,266 +14,641	+57%	+$6.99M	0.39%	29
2020 Q4	$11.9M	Buy	+25,625	New	+$12M	0.31%	52
2020 Q3	–	Sell	-24,437	Closed	-$10.1M	–	2454
2020 Q2	$8.86M	Buy	24,437 +17,233	+239%	+$5.78M	0.15%	128
2020 Q1	$2.04M	Sell	7,204 -6,531	-48%	-$2.06M	0.11%	127
2019 Q4	$4.46M	Buy	+13,735	New	+$4.16M	0.07%	278
2019 Q3	–	Sell	-7,488	Closed	-$2.2M	–	2286
2019 Q2	$2.2M	Buy	7,488 +3,622	+94%	+$998K	0.04%	389
2019 Q1	$1.06M	Sell	3,866 -2,807	-42%	-$699K	0.03%	703
2018 Q4	$1.49M	Buy	6,673 +4,409	+195%	+$1.03M	0.05%	322
2018 Q3	$553K	Buy	2,264 +228	+11%	+$52.5K	0.01%	990
2018 Q2	$421K	Sell	2,036 -12,010	-86%	-$2.55M	0.01%	1107
2018 Q1	$2.9M	Buy	14,046 +6,216	+79%	+$1.3M	0.05%	384
2017 Q4	$1.49M	Sell	7,830 -617	-7%	-$118K	0.02%	822
2017 Q3	$1.6M	Sell	8,447 -10,654	-56%	-$1.93M	0.02%	882
2017 Q2	$3.33M	Sell	19,101 -13,813	-42%	-$2.32M	0.04%	468
2017 Q1	$5.05M	Buy	32,914 +19,374	+143%	+$2.96M	0.06%	300
2016 Q4	$1.91M	Buy	+13,540	New	+$2M	0.02%	705
2016 Q3	–	Sell	-21,511	Closed	-$3.18M	–	2128
2016 Q2	$3.18M	Sell	21,511 -31,544	-59%	-$4.66M	0.04%	439
2016 Q1	$7.51M	Buy	53,055 +36,004	+211%	+$4.83M	0.12%	107
2015 Q4	$2.42M	Buy	17,051 +6,260	+58%	+$835K	0.06%	297
2015 Q3	$1.32M	Buy	10,791 +7,851	+267%	+$1.02M	0.03%	504
2015 Q2	$381K	Sell	2,940 -6,410	-69%	-$836K	0.01%	1214
2015 Q1	$1.26M	Sell	9,350 -7,331	-44%	-$945K	0.04%	427
2014 Q4	$2.09M	Buy	16,681 +11,745	+238%	+$1.43M	0.09%	249
2014 Q3	$600K	Buy	+4,936	New	+$600K	0.03%	474
2013 Q3	–	Sell	-2,442	Closed	-$207K	–	1185
2013 Q2	$207K	Buy	+2,442	New	+$203K	0.01%	891

Other funds holding TMO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Paloma Partners's TMO Position: Q4 2024 in Review

Paloma Partners sold out of Thermo Fisher Scientific (TMO) in Q4 2024, closing a stake of 1,300 shares — an estimated $804K sold.

Paloma Partners first reported a position in TMO in Q2 2013 and held it in 32 quarters. The position peaked at $18.4M in Q1 2021. 2,616 funds tracked by Wall St. Rank hold TMO as of Q4 2024.

Paloma Partners reported no remaining Thermo Fisher Scientific position as of Q4 2024 after selling out during the quarter.
Paloma Partners sold 1,300 Thermo Fisher Scientific shares in Q4 2024, an estimated $804K.
Paloma Partners first reported a position in Thermo Fisher Scientific in Q2 2013 and held it in 32 quarters.
Paloma Partners's Thermo Fisher Scientific position peaked at $18.4M in Q1 2021.
2,616 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q4 2024.

Based on Paloma Partners's 13F filing for Q4 2024, filed 14 Feb 2025.